The Rapid Evolution of Multiple Myeloma Treatment in Recent Years

Multiple myeloma, once considered a disease with a poor prognosis, has experienced a revolution in treatment over the past decade with the emergence of new approaches, such as CAR T-cell therapy and bispecific T-cell engagers. As other novel therapies progress through the development pipeline, investigators will have to consider a variety of patient-specific factors when selecting and sequencing treatments, but the future of the field is bright.